Somatic MIWI2 Hinders Direct Lineage Reprogramming From Fibroblast to Hepatocyte

Area of Science:

• Cell biology
• Epigenetics
• Molecular biology

Background:

• Cellular reprogramming requires gene regulatory network remodeling.
• Key regulatory factors for lineage reprogramming remain largely unknown.

Purpose of the Study:

• To investigate the role of PIWI proteins, specifically MIWI2, in fibroblast-to-hepatocyte transdifferentiation.
• To elucidate the mechanisms by which MIWI2 influences cell plasticity.

Main Methods:

• Investigated MIWI2 expression during fibroblast transdifferentiation.
• Analyzed Piwi-interacting RNA (piRNA) profiles.
• Utilized gene knockout and overexpression of MIWI2.
• Performed bioinformatics analysis of piRNA interaction networks.
• Experimentally validated findings, including Notch signaling pathway interactions.

Main Results:

• MIWI2 is transiently expressed during fibroblast-to-hepatocyte-like cell transdifferentiation.
• A unique epigenetic state with a specific piRNA profile emerges during MIWI2 peak expression.
• MIWI2 knockout enhances induced hepatocyte formation.
• MIWI2 overexpression inhibits stimulated hepatocyte formation.
• The Notch signaling pathway is identified as a key effector of MIWI2.

Conclusions:

• Temporal expression of MIWI2 negatively impacts cell plasticity in somatic cells like mouse fibroblasts.
• MIWI2 acts as a repressor of cell reprogramming, extending its known role beyond the germline.
• Understanding MIWI2's function provides insights into controlling cell fate and reprogramming efficiency.